Event-Triggered Model Predictive Control For Embedded Artificial Pancreas Systems
Check out our most recent publication, regarding a power-efficient algorithm for implementing the artificial pancreas on a chip! See the preprint here.
News
Artificial pancreas clinical trials open
Harvard SEAS: Trials test system to automatically regulate blood sugar for people with type 1 diabetes.
Frank Doyle Elected to National Academy of Medicine
Francis J. Doyle III, Dean of the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS), has been elected to the National Academy of Medicine (NAM). Read more here: Harvard SEAS: Frank Doyle Elected to National Academy of Medicine
Two new DoyleGroup Ph.D.s!
Congratulations to Dr. Lauren Huyett and Dr. Joon Bok Lee both of whom successfully defended their dissertations this morning! We will miss their presence in our lab, but we are excited to see what great accomplishments lie ahead.
Mapping the circuit of our internal clock
Harvard SEAS: “Research sheds light the neural structure that controls our sleep, eating habits, hormones and more.” See within for press from our most recent study of the circadian clock. Harvard SEAS: here UCSB Current: here This has been featured elsewhere, including: ExtremeTech The Daily Mail
ScienceDaily: Researchers reveal, to single-cell resolution, the network of circadian neurons
While the overall effects of circadian activities have been studied, relatively little is understood about the structure of the network of brain cells as they communicate to control the synchronization process. In a paper that appears in the Proceedings of the National Academy of Sciences, UC Santa Barbara [and Harvard!] researchers and collaborators infer the […]
Insulet Announces Development Partner for the OmniPod Artificial Pancreas
“Insulet Corporation today announced a license agreement and partnership with Mode AGC (Automated Glucose Control LLC), to develop and incorporate the advanced artificial pancreas algorithm created by renowned researchers Francis Doyle PhD, Eyal Dassau PhD, and Howard Zisser MD.”
Care and Cure: Engineering the future of diabetes treatment – Reuters
Research from the Doyle Group was recently featured in Reuters. See the article to hear about ongoing work with the artificial pancreas, and an interview with Frank Doyle.
